title: Altered endothelin receptor binding in response to nitric oxide synthase inhibition in the pregnant rat.
abstract: The authors evaluate the expression of endothelin-1 (ET-1) and its receptors in the uterus and placenta during maternal nitric oxide synthase (NOS) inhibition. Timed-pregnant rats received L-NAME (2.5 mg/kg/h) or saline from day 14 to 21 of gestation. Uterine and placental tissues collected on day 21 were assayed for preproET-1, ET( A), and ET(B) mRNA expression; localization and expression of ET-1 and receptor proteins; and receptor activity. NOS inhibition did not affect preproET-1 mRNA expression in the placenta or uterus. ET(A) expression decreased in the uterine free wall, but no other changes in receptor mRNA expression were observed in the uterus or placenta. ET-1 and receptor proteins were unchanged. Placental ET(A) and ET(B) receptor binding decreased. Uterine ET(A) receptor binding decreased in the placental bed. ET-1, a prominent mediator during NOS inhibition, is not of uterine or placental origin. Reduced receptor binding activity is the primary means by which these tissues regulate their response to ET-1 in the setting of NOS inhibition.
authors.affiliation: Department of Obstetrics, Evanston Northwestern Healthcare, Evanston, Illinois, USA.
authors.forename: Mark G
authors.initials: MG
authors.lastname: Neerhof
authors.forename: Tamas
authors.initials: T
authors.lastname: Jilling
authors.forename: Sylvia
authors.initials: S
authors.lastname: Synowiec
authors.forename: Saira
authors.initials: S
authors.lastname: Khan
authors.forename: Larry G
authors.initials: LG
authors.lastname: Thaete
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001667:Binding, Competitive; D015153:Blotting, Western; D019332:Endothelin-1 / Q000235:genetics / Q000378:metabolism*; D019334:Endothelin-3 / Q000378:metabolism; D005260:Female; D015870:Gene Expression; D007150:Immunohistochemistry; D007457:Iodine Radioisotopes; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors* / Q000502:physiology; D010920:Placenta / Q000033:anatomy & histology / Q000187:drug effects* / Q000378:metabolism; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D044022:Receptor, Endothelin A / Q000235:genetics / Q000378:metabolism*; D044023:Receptor, Endothelin B / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014599:Uterus / Q000033:anatomy & histology / Q000187:drug effects* / Q000378:metabolism
chemical_list: D019332:Endothelin-1; D019334:Endothelin-3; D007457:Iodine Radioisotopes; D012333:RNA, Messenger; D044022:Receptor, Endothelin A; D044023:Receptor, Endothelin B; D019001:Nitric Oxide Synthase; D019331:NG-Nitroarginine Methyl Ester